Top 40 Medical VC Funds in Austria
A list of 40 VC funds that invest in Medical startups based in Austria. We rank investors based on the number of investments they made in Medical companies from Austria. We update this investor list every month.Top 40 Medical VC Funds in Austria
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guideclimate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Germany, Austria, United Kingdom
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Orderlion is aiming to become the gold standard for online ordering of restaurants & hotels from all their suppliers. Orderlion is already available in more than 20 cities in Austria, Germany, the Czech Republic, Switzerland and France with over 1.000 restaurants and hundreds of suppliers.Orderlion was designed for all types of hospitalitybusinesses (café, restaurant, hotel, chain). The order platform combines all suppliers and products in one app and enables customer-specific pricing. With little effort, the entire inventory of restaurants can be recorded and activated for automatic ordering processes. Orderlion counts numerous prominent restaurants among its customers. Orderlion was founded by Stefan Strohmer and Patrick Schubert in 2018 and has its headquarters in Vienna, Austria.
- VALANX Biotech — Protein conjugation. Specific, fast and cost effective.
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Germany, Austria, Canada
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Information Technology, Software, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- Neotiv — Enabling cognitive health
- RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
- InLine-Med — Radiologists perform safe, precise & easy interventions with the InLine-Med surgical tools and assistance devices.
Multi family office investing in proptech, digital health & sustainability
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- Austria, Germany
Portfolio highlights
- contextflow — Improve your radiology workflows with our clinical decision support system, clinical applications and deep learning-based tools.
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Series A, Series B, Seed
- United States, India, Singapore
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Qoala — Asuransi online yang siap melindungi kamu dan orang tersayang, di mana aja, kapan aja. Premi murah, proses klaim mudah, dan 100% digital!
- Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort
FCPG Affi
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
- CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Grant, Pre-Seed
- Austria, Belgium
Portfolio highlights
- HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
- revitalyze — revitalyze is an award-winning greentech platform that enables a circular construction industry through a unique approach to the reuse of building elements.
- Lightning Company — The Lightning Company is the first EU-based bitcoin and lightning payment gateway. We want to make bitcoin payments as easy and attractive as possible, ensuring that customers have no additional costs, whilst merchants receive attractive processing fees.
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more
Investment focus
- Electronics, Software, Medical Device
- Funding Round, Seed, Series A
- Germany, Austria
Portfolio highlights
- Wingfield — Wingfield ist dein Zugang zu einem virtuellen Tenniserlebnis.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
- COMAN Software — COMAN Software provides innovative software for project management in machine and plant construction.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more
Investment focus
- Sensor, Medical, Wireless
- Series B, Funding Round
- Austria
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.
Show more
Investment focus
- Software, Biotechnology, Telecommunications
- Funding Round, Seed
- Austria, Germany
Portfolio highlights
- Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
- a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
| Investments that move industries
Show more
Investment focus
- Software, Apps, Health Care
- Seed, Series A, Funding Round
- Austria, Germany, United States
Portfolio highlights
- Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
- FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
- Ohana — Ohana helps you to protect your child in the digital world. Limit screentime, get insights & guidance, block apps & websites and filter inappropriate content.
The typical market transaction involves the sale of one company at a time. However, there are situations where disposing of holdings in a number of businesses, in a single transaction, brings significant benefits - together with substantial time and cost efficiencies.Whether seeking a solution to illiquidity, the disposal of legacy assets orthe freedom to implement strategic change, Nova offers the corporate and financial sellers an efficient and market value solution. Unlocked from their holdings, investors and owners are better positioned to focus on the benefits and opportunities this significant step change brings.Although principally an acquirer, Nova can also work with investors in private equity funds, where there is the need for a Replacement Manager or General Partner.
Show more
Investment focus
- Software, Artificial Intelligence, Automotive
- Seed, Series A, Series C
- Italy, Poland, Austria
Portfolio highlights
- Roboze — Roboze is able to engineer high performance thermoplastic polymers resistant to the most extreme operating conditions for various sectors.
- contextflow — Improve your radiology workflows with our clinical decision support system, clinical applications and deep learning-based tools.
- Cardiomatics — Cardiomatics is a cloud AI tool for ECG analysis.Simply give us a raw ECG signal and our algorithms will turn it into valuable analysis.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series B, Funding Round, Series C
- United States, Germany, Switzerland
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
- Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more
Investment focus
- Software, Manufacturing, RFID
- Series A, Series B, Series C
- Austria, Germany
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Series C, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, Germany, United Kingdom
Portfolio highlights
- Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
- Revolt Technology — News & Informations
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
Entrepreneurs for Entrepreneurs
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Series A, Seed, Series B
- Austria, Switzerland
Portfolio highlights
- Finmatics — Finmatics is a self-learning, artificial intelligence system that automates the activities of accounting service providers. It adapts itself to the unique bookkeeping requirements of companies, industries, and countries by analyzing the activities of human accountants.
- Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
- Autonoma Technologies — Autonoma Technologies is an information technology company that specializes in the digitalization of customer platforms.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
MMC is a venture capital fund investing in early stage, high-growth UK companies. Investing in technology companies at Seed and Series A.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series A, Seed, Funding Round
- United Kingdom, United States, France
Portfolio highlights
- Kerno — Instantly identify the root cause of any critical issue in your Cloud apps and get back to business in minutes, not hours.
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
- Eatron Technologies — Redefining Automotive Software - Intelligent Software Platform for Battery Management System & Intelligent Motion Control
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Hello, our name is ROXand we are taking digital healthcare to the streets.
Show more
Investment focus
- Health Care, Health Diagnostics, Apps
- Pre-Seed, Seed
- Germany, Austria
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
LANA Ventures is a venture capital firm.
Show more
Investment focus
- Apps, Medical, mHealth
- Seed
- Austria
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.
Show more
Investment focus
- Health Care, Medical, Wellness
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Denmark
Portfolio highlights
- Jude — Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Pear Bio — Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more
Investment focus
- Artificial Intelligence, Health Care, Life Science
- Seed, Series A, Pre-Seed
- Germany, Austria
Portfolio highlights
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
- keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
GLS Ventures
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series B, Funding Round
- Austria
Portfolio highlights
- Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Austria, United States, Germany
Portfolio highlights
- Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
- ToolSense — Connecting the way OEMs do business.ToolSense enables OEMs to improve customer service, generate insights for R&D and increase customer loyalty - through digitizing their products with the 'ToolSense NOW' IIoT platform and 'ToolSense IOT' Hardware.ToolSense is the winner of Austrian Foreign Trade Award "Born GlobalChampion 2018", ORF Futurezone Award "Best IoT Startup 2017", part of Deutsche Telekom's "hub:raum NB-IoT Warp Program", part of SAP's "Startup Focus Program" and part of University of Applied Sciences Technikum Vienna's "Student Startup Incubator Program".
- Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food
Biopart
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.
Show more
Investment focus
- Biotechnology, Energy, Medical
- Funding Round, Series B, Series C
- Germany, Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
- Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- Germany, Austria, Ireland
Portfolio highlights
- Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
- Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Investment Company
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.
Show more
Investment focus
- Mobile, iOS, Mobile Apps
- Series A, Seed, Series C
- Austria, Switzerland, United States
Portfolio highlights
- Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
- 42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- United States, Japan, Germany
Portfolio highlights
- Cogsmart — Cogsmart provides services for brain function research and development. In hopes of helping prevent dementia and maintain and improve other cognitive functions, they manufacture and sell software for medical and healthcare devices.
- Tupu — Tupu engages in the manufacture and supply of mushroom-based foods.
- German Bionic — German Bionic is backed by renowned international technology investors such as Samsung Catalyst Fund, Storm Ventures and MIG, which is also invested in Covid-19 vaccine developer BioNTech. The company and its products are regularly featured in top-tier publications and are the recipients of numerous awards including the German Entrepreneur Award,the Land of Ideas Award, the Automatica Award as well as a nomination for Hannover Messe’s coveted Hermes Award.The German Bionic Cray X is the world’s first connected exoskeleton. Linked to the Smart Factory, it self-learns to reinforce lifting movements and prevent incorrect posture, thus becoming an intelligent link between humans and machines. In doing so, it delivers data that underscores its ability to protect the health of workers, measurably reduce the risk of accidents, and thereby make quantifiable improvements to work processes.
Investor
Show more
Investment focus
- Medical, Analytics, Health Diagnostics
- Series A
- Austria
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that supports you by offering an AI-powered experience that takes your business to the next level and provides your patients with personalized access to better understand and manage their health
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Photography
Fashion
Education
B2B
Renewable Energy
Payments
Financial Services
Sporting Goods
Finance
Retail
Medical
Email
Wellness
Social Media
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Recruiting
Social Network
Platforms
Travel
Fitness
Manufacturing
Mobile Advertising
Digital Media
Cannabis
Biotechnology
Facebook
Hospitality
Art
Automotive
Crowdfunding
Wine And Spirits
Medical Device
Social
Social Impact
CleanTech
Transportation
Mobile Apps
Enterprise
InsurTech
SaaS
LGBT
Film
Life Science
Theatre
Non Profit
Software
Cryptocurrency
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Kuwait
Georgia
Gibraltar
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Cameroon
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Chile
Mauritius
Morocco
Malaysia
Norway
Finland
Peru
Myanmar
Cayman Islands
Panama
Estonia
Malta
Mexico
Seychelles
Slovenia
Faroe Islands
Greece
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ethiopia
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Ghana
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Hungary
Nigeria
Bahamas
Croatia
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Egypt
Honduras
Belgium
Barbados
Isle of Man
Bolivia
Ecuador
Luxembourg
France
Pakistan
Hong Kong
Albania
Argentina
Austria
Bangladesh
Grenada
Jordan
Romania
Colombia
Cyprus
Latvia
Oman
Switzerland
Guatemala
Marshall Islands
VC Funds in Austria by industry
CleanTech
Media (entertainment)
Transportation
Big Data
Cryptocurrency
Education
Finance
Food and Beverage
Payments
Organic Food
Medical Device
Wellness
Internet
Manufacturing
Mobile
Android
Blockchain
Software
Local
Enterprise Software
eSports
Sports
Automotive
Fitness
Travel
Hospitality
Platforms
Recruiting
FinTech
Biotechnology
Enterprise
Real Estate
Consumer
Health Care
Biotech
Energy
EdTech
Climate
Impact
Marketplace
SaaS
Community
Artificial intelligence
Gaming
Hardware
Web3
Mobile Apps
Life Science
Renewable Energy
Financial Services
Medical
Music
Construction
InsurTech
Social Media
Retail
Proptech
Sustainability